Back to Learn
NAD+Guide2 min read

NAD+ Injections and Infusions: Sterile-Compounding Questions

The FDA has warned that food-grade NAD+ is unsuitable for sterile compounding without appropriate processing because microbial and endotoxin contamination can harm patients. Ask about the actual preparation, pharmacy, quality controls, and adverse-event response before interpreting a purity claim as an assurance of injectable quality.

By PacificRx editorial team · Published

At a glance

The FDA has warned that food-grade NAD+ is unsuitable for sterile compounding without appropriate processing because microbial and endotoxin contamination can harm patients. Ask about the actual preparation, pharmacy, quality controls, and adverse-event response before interpreting a purity claim as an assurance of injectable quality.

  • Food-grade material is not automatically suitable for injection.
  • Chemical purity and sterile quality are different questions.
  • Know the dispensing pharmacy and clinical contact route.
This article is educational and is not medical advice. A licensed clinician must review your medical history before determining whether treatment is appropriate.Read our editorial standards.

Why does ingredient suitability matter?

Injectable and intravenous products introduce preparation requirements that differ from those of products intended to be swallowed. The FDA's warning specifically discusses compounders using food-grade NAD+ sold by repackagers in intravenous products.

The agency identifies contamination with microbes and endotoxins as a concern. A description of a substance's biological role does not establish that the material used to prepare an injectable product is appropriate.

Is a purity certificate enough?

A report may describe chemical identity or purity for a sample without addressing every requirement for a sterile preparation. Ask what the report measured, which sample it covers, and which quality questions remain outside its scope.

Likewise, a certificate for an ingredient is different from information about the final dispensed preparation. Do not assume one document establishes formulation accuracy, appropriate handling, sterile quality, and clinical suitability together.

What should I ask the care team?

Confirm the pharmacy's identity, relevant licensing, exact product and route, storage instructions, and how to contact a pharmacist. Ask how potential reactions are handled and whom to contact when an adverse effect is suspected.

Severe or urgent symptoms need prompt medical care rather than a routine portal message. Keep the product label accessible for the treating team. A compounded preparation is not FDA-approved before marketing, and quality questions remain separate from questions about whether a treatment provides a benefit.

Sources